Table of Content

1 Study Coverage
1.1 PDE 4 Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global PDE 4 Inhibitors Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 Rolipram
1.2.3 Tetomilast
1.2.4 Cilomilast
1.2.5 Criborole
1.2.6 Apremilast
1.2.7 Roflumilast
1.2.8 Others
1.3 Market by Application
1.3.1 Global PDE 4 Inhibitors Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Psoriasis
1.3.3 Chronic Obstructive Pulmonary Disease (COPD)
1.3.4 Asthma
1.3.5 Ankylosing Spondylitis (AS)
1.3.6 Inflammatory Bowel Disease (IBD)
1.3.7 Atopic Dermatitis
1.3.8 Rheumatoid Arthritis (RA)
1.3.9 Systemic Lupus Erythematosus (SLE)
1.3.10 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global PDE 4 Inhibitors Sales Estimates and Forecasts 2024-2034
2.2 Global PDE 4 Inhibitors Revenue by Region
2.2.1 Global PDE 4 Inhibitors Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global PDE 4 Inhibitors Revenue by Region (2024-2024)
2.2.3 Global PDE 4 Inhibitors Revenue by Region (2024-2034)
2.2.4 Global PDE 4 Inhibitors Revenue Market Share by Region (2024-2034)
2.3 Global PDE 4 Inhibitors Sales Estimates and Forecasts 2024-2034
2.4 Global PDE 4 Inhibitors Sales by Region
2.4.1 Global PDE 4 Inhibitors Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global PDE 4 Inhibitors Sales by Region (2024-2024)
2.4.3 Global PDE 4 Inhibitors Sales by Region (2024-2034)
2.4.4 Global PDE 4 Inhibitors Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global PDE 4 Inhibitors Sales by Manufacturers
3.1.1 Global PDE 4 Inhibitors Sales by Manufacturers (2024-2024)
3.1.2 Global PDE 4 Inhibitors Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of PDE 4 Inhibitors in 2022
3.2 Global PDE 4 Inhibitors Revenue by Manufacturers
3.2.1 Global PDE 4 Inhibitors Revenue by Manufacturers (2024-2024)
3.2.2 Global PDE 4 Inhibitors Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by PDE 4 Inhibitors Revenue in 2022
3.3 Global Key Players of PDE 4 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global PDE 4 Inhibitors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global PDE 4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of PDE 4 Inhibitors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of PDE 4 Inhibitors, Product Offered and Application
3.8 Global Key Manufacturers of PDE 4 Inhibitors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global PDE 4 Inhibitors Sales by Type
4.1.1 Global PDE 4 Inhibitors Historical Sales by Type (2024-2024)
4.1.2 Global PDE 4 Inhibitors Forecasted Sales by Type (2024-2034)
4.1.3 Global PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
4.2 Global PDE 4 Inhibitors Revenue by Type
4.2.1 Global PDE 4 Inhibitors Historical Revenue by Type (2024-2024)
4.2.2 Global PDE 4 Inhibitors Forecasted Revenue by Type (2024-2034)
4.2.3 Global PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
4.3 Global PDE 4 Inhibitors Price by Type
4.3.1 Global PDE 4 Inhibitors Price by Type (2024-2024)
4.3.2 Global PDE 4 Inhibitors Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global PDE 4 Inhibitors Sales by Application
5.1.1 Global PDE 4 Inhibitors Historical Sales by Application (2024-2024)
5.1.2 Global PDE 4 Inhibitors Forecasted Sales by Application (2024-2034)
5.1.3 Global PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
5.2 Global PDE 4 Inhibitors Revenue by Application
5.2.1 Global PDE 4 Inhibitors Historical Revenue by Application (2024-2024)
5.2.2 Global PDE 4 Inhibitors Forecasted Revenue by Application (2024-2034)
5.2.3 Global PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
5.3 Global PDE 4 Inhibitors Price by Application
5.3.1 Global PDE 4 Inhibitors Price by Application (2024-2024)
5.3.2 Global PDE 4 Inhibitors Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada PDE 4 Inhibitors Market Size by Type
6.1.1 US & Canada PDE 4 Inhibitors Sales by Type (2024-2034)
6.1.2 US & Canada PDE 4 Inhibitors Revenue by Type (2024-2034)
6.2 US & Canada PDE 4 Inhibitors Market Size by Application
6.2.1 US & Canada PDE 4 Inhibitors Sales by Application (2024-2034)
6.2.2 US & Canada PDE 4 Inhibitors Revenue by Application (2024-2034)
6.3 US & Canada PDE 4 Inhibitors Market Size by Country
6.3.1 US & Canada PDE 4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada PDE 4 Inhibitors Sales by Country (2024-2034)
6.3.3 US & Canada PDE 4 Inhibitors Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe PDE 4 Inhibitors Market Size by Type
7.1.1 Europe PDE 4 Inhibitors Sales by Type (2024-2034)
7.1.2 Europe PDE 4 Inhibitors Revenue by Type (2024-2034)
7.2 Europe PDE 4 Inhibitors Market Size by Application
7.2.1 Europe PDE 4 Inhibitors Sales by Application (2024-2034)
7.2.2 Europe PDE 4 Inhibitors Revenue by Application (2024-2034)
7.3 Europe PDE 4 Inhibitors Market Size by Country
7.3.1 Europe PDE 4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe PDE 4 Inhibitors Sales by Country (2024-2034)
7.3.3 Europe PDE 4 Inhibitors Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China PDE 4 Inhibitors Market Size
8.1.1 China PDE 4 Inhibitors Sales (2024-2034)
8.1.2 China PDE 4 Inhibitors Revenue (2024-2034)
8.2 China PDE 4 Inhibitors Market Size by Application
8.2.1 China PDE 4 Inhibitors Sales by Application (2024-2034)
8.2.2 China PDE 4 Inhibitors Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia PDE 4 Inhibitors Market Size by Type
9.1.1 Asia PDE 4 Inhibitors Sales by Type (2024-2034)
9.1.2 Asia PDE 4 Inhibitors Revenue by Type (2024-2034)
9.2 Asia PDE 4 Inhibitors Market Size by Application
9.2.1 Asia PDE 4 Inhibitors Sales by Application (2024-2034)
9.2.2 Asia PDE 4 Inhibitors Revenue by Application (2024-2034)
9.3 Asia PDE 4 Inhibitors Sales by Region
9.3.1 Asia PDE 4 Inhibitors Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia PDE 4 Inhibitors Revenue by Region (2024-2034)
9.3.3 Asia PDE 4 Inhibitors Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America PDE 4 Inhibitors Market Size by Type
10.1.1 Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America PDE 4 Inhibitors Market Size by Application
10.2.1 Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Country
10.3.1 Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer(Anacor)
11.1.1 Pfizer(Anacor) Company Information
11.1.2 Pfizer(Anacor) Overview
11.1.3 Pfizer(Anacor) PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 Pfizer(Anacor) PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer(Anacor) Recent Developments
11.2 Arcutis Biotherapeutics
11.2.1 Arcutis Biotherapeutics Company Information
11.2.2 Arcutis Biotherapeutics Overview
11.2.3 Arcutis Biotherapeutics PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Arcutis Biotherapeutics PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Arcutis Biotherapeutics Recent Developments
11.3 UNION Therapeutics
11.3.1 UNION Therapeutics Company Information
11.3.2 UNION Therapeutics Overview
11.3.3 UNION Therapeutics PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 UNION Therapeutics PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 UNION Therapeutics Recent Developments
11.4 Innovent Biologics, Inc.
11.4.1 Innovent Biologics, Inc. Company Information
11.4.2 Innovent Biologics, Inc. Overview
11.4.3 Innovent Biologics, Inc. PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.4.4 Innovent Biologics, Inc. PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Innovent Biologics, Inc. Recent Developments
11.5 Amgen
11.5.1 Amgen Company Information
11.5.2 Amgen Overview
11.5.3 Amgen PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.5.4 Amgen PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amgen Recent Developments
11.6 Ralington pharma LLP
11.6.1 Ralington pharma LLP Company Information
11.6.2 Ralington pharma LLP Overview
11.6.3 Ralington pharma LLP PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.6.4 Ralington pharma LLP PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ralington pharma LLP Recent Developments
11.7 Beijing Biolab Technology Co., Ltd.
11.7.1 Beijing Biolab Technology Co., Ltd. Company Information
11.7.2 Beijing Biolab Technology Co., Ltd. Overview
11.7.3 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.7.4 Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Biolab Technology Co., Ltd. Recent Developments
11.8 Nycomed
11.8.1 Nycomed Company Information
11.8.2 Nycomed Overview
11.8.3 Nycomed PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.8.4 Nycomed PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nycomed Recent Developments
11.9 Forest
11.9.1 Forest Company Information
11.9.2 Forest Overview
11.9.3 Forest PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.9.4 Forest PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Forest Recent Developments
11.10 Bristol Myers
11.10.1 Bristol Myers Company Information
11.10.2 Bristol Myers Overview
11.10.3 Bristol Myers PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.10.4 Bristol Myers PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Bristol Myers Recent Developments
11.11 GSK
11.11.1 GSK Company Information
11.11.2 GSK Overview
11.11.3 GSK PDE 4 Inhibitors Sales, Price, Revenue and Gross Margin (2024-2024)
11.11.4 GSK PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 PDE 4 Inhibitors Industry Chain Analysis
12.2 PDE 4 Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 PDE 4 Inhibitors Production Mode & Process
12.4 PDE 4 Inhibitors Sales and Marketing
12.4.1 PDE 4 Inhibitors Sales Channels
12.4.2 PDE 4 Inhibitors Distributors
12.5 PDE 4 Inhibitors Customers
13 Market Dynamics
13.1 PDE 4 Inhibitors Industry Trends
13.2 PDE 4 Inhibitors Market Drivers
13.3 PDE 4 Inhibitors Market Challenges
13.4 PDE 4 Inhibitors Market Restraints
14 Key Findings in The Global PDE 4 Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global PDE 4 Inhibitors Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Rolipram
Table 3. Major Manufacturers of Tetomilast
Table 4. Major Manufacturers of Cilomilast
Table 5. Major Manufacturers of Criborole
Table 6. Major Manufacturers of Apremilast
Table 7. Major Manufacturers of Roflumilast
Table 8. Major Manufacturers of Others
Table 9. Global PDE 4 Inhibitors Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 10. Global PDE 4 Inhibitors Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 11. Global PDE 4 Inhibitors Revenue by Region (2024-2024) & (US$ Million)
Table 12. Global PDE 4 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global PDE 4 Inhibitors Revenue Market Share by Region (2024-2024)
Table 14. Global PDE 4 Inhibitors Revenue Market Share by Region (2024-2034)
Table 15. Global PDE 4 Inhibitors Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 16. Global PDE 4 Inhibitors Sales by Region (2024-2024) & (K Units)
Table 17. Global PDE 4 Inhibitors Sales by Region (2024-2034) & (K Units)
Table 18. Global PDE 4 Inhibitors Sales Market Share by Region (2024-2024)
Table 19. Global PDE 4 Inhibitors Sales Market Share by Region (2024-2034)
Table 20. Global PDE 4 Inhibitors Sales by Manufacturers (2024-2024) & (K Units)
Table 21. Global PDE 4 Inhibitors Sales Share by Manufacturers (2024-2024)
Table 22. Global PDE 4 Inhibitors Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 23. Global PDE 4 Inhibitors Revenue Share by Manufacturers (2024-2024)
Table 24. Global Key Players of PDE 4 Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 25. PDE 4 Inhibitors Price by Manufacturers 2024-2024 (US$/Unit)
Table 26. Global PDE 4 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global PDE 4 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PDE 4 Inhibitors as of 2022)
Table 28. Global Key Manufacturers of PDE 4 Inhibitors, Manufacturing Base Distribution and Headquarters
Table 29. Global Key Manufacturers of PDE 4 Inhibitors, Product Offered and Application
Table 30. Global Key Manufacturers of PDE 4 Inhibitors, Date of Enter into This Industry
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 33. Global PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 34. Global PDE 4 Inhibitors Sales Share by Type (2024-2024)
Table 35. Global PDE 4 Inhibitors Sales Share by Type (2024-2034)
Table 36. Global PDE 4 Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 37. Global PDE 4 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 38. Global PDE 4 Inhibitors Revenue Share by Type (2024-2024)
Table 39. Global PDE 4 Inhibitors Revenue Share by Type (2024-2034)
Table 40. PDE 4 Inhibitors Price by Type (2024-2024) & (US$/Unit)
Table 41. Global PDE 4 Inhibitors Price Forecast by Type (2024-2034) & (US$/Unit)
Table 42. Global PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 43. Global PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 44. Global PDE 4 Inhibitors Sales Share by Application (2024-2024)
Table 45. Global PDE 4 Inhibitors Sales Share by Application (2024-2034)
Table 46. Global PDE 4 Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 47. Global PDE 4 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 48. Global PDE 4 Inhibitors Revenue Share by Application (2024-2024)
Table 49. Global PDE 4 Inhibitors Revenue Share by Application (2024-2034)
Table 50. PDE 4 Inhibitors Price by Application (2024-2024) & (US$/Unit)
Table 51. Global PDE 4 Inhibitors Price Forecast by Application (2024-2034) & (US$/Unit)
Table 52. US & Canada PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 53. US & Canada PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 54. US & Canada PDE 4 Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 55. US & Canada PDE 4 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 56. US & Canada PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 57. US & Canada PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 58. US & Canada PDE 4 Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 59. US & Canada PDE 4 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 60. US & Canada PDE 4 Inhibitors Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 61. US & Canada PDE 4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 62. US & Canada PDE 4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 63. US & Canada PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 64. US & Canada PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 65. Europe PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 66. Europe PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 67. Europe PDE 4 Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 68. Europe PDE 4 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 70. Europe PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 71. Europe PDE 4 Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 72. Europe PDE 4 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe PDE 4 Inhibitors Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 74. Europe PDE 4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 75. Europe PDE 4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 77. Europe PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 78. China PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 79. China PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 80. China PDE 4 Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 81. China PDE 4 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 82. China PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 83. China PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 84. China PDE 4 Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 85. China PDE 4 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 86. Asia PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 87. Asia PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 88. Asia PDE 4 Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 89. Asia PDE 4 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 90. Asia PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 91. Asia PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 92. Asia PDE 4 Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 93. Asia PDE 4 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 94. Asia PDE 4 Inhibitors Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 95. Asia PDE 4 Inhibitors Revenue by Region (2024-2024) & (US$ Million)
Table 96. Asia PDE 4 Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 97. Asia PDE 4 Inhibitors Sales by Region (2024-2024) & (K Units)
Table 98. Asia PDE 4 Inhibitors Sales by Region (2024-2034) & (K Units)
Table 99. Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Type (2024-2024) & (K Units)
Table 100. Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Type (2024-2034) & (K Units)
Table 101. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Type (2024-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Type (2024-2034) & (US$ Million)
Table 103. Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Application (2024-2024) & (K Units)
Table 104. Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Application (2024-2034) & (K Units)
Table 105. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Application (2024-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Application (2024-2034) & (US$ Million)
Table 107. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 108. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Country (2024-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Country (2024-2024) & (K Units)
Table 111. Middle East, Africa and Latin America PDE 4 Inhibitors Sales by Country (2024-2034) & (K Units)
Table 112. Pfizer(Anacor) Company Information
Table 113. Pfizer(Anacor) Description and Major Businesses
Table 114. Pfizer(Anacor) PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Pfizer(Anacor) PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Pfizer(Anacor) Recent Developments
Table 117. Arcutis Biotherapeutics Company Information
Table 118. Arcutis Biotherapeutics Description and Major Businesses
Table 119. Arcutis Biotherapeutics PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Arcutis Biotherapeutics PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Arcutis Biotherapeutics Recent Developments
Table 122. UNION Therapeutics Company Information
Table 123. UNION Therapeutics Description and Major Businesses
Table 124. UNION Therapeutics PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. UNION Therapeutics PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. UNION Therapeutics Recent Developments
Table 127. Innovent Biologics, Inc. Company Information
Table 128. Innovent Biologics, Inc. Description and Major Businesses
Table 129. Innovent Biologics, Inc. PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Innovent Biologics, Inc. PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Innovent Biologics, Inc. Recent Developments
Table 132. Amgen Company Information
Table 133. Amgen Description and Major Businesses
Table 134. Amgen PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Amgen PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Amgen Recent Developments
Table 137. Ralington pharma LLP Company Information
Table 138. Ralington pharma LLP Description and Major Businesses
Table 139. Ralington pharma LLP PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Ralington pharma LLP PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Ralington pharma LLP Recent Developments
Table 142. Beijing Biolab Technology Co., Ltd. Company Information
Table 143. Beijing Biolab Technology Co., Ltd. Description and Major Businesses
Table 144. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Beijing Biolab Technology Co., Ltd. PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Beijing Biolab Technology Co., Ltd. Recent Developments
Table 147. Nycomed Company Information
Table 148. Nycomed Description and Major Businesses
Table 149. Nycomed PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Nycomed PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Nycomed Recent Developments
Table 152. Forest Company Information
Table 153. Forest Description and Major Businesses
Table 154. Forest PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Forest PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Forest Recent Developments
Table 157. Bristol Myers Company Information
Table 158. Bristol Myers Description and Major Businesses
Table 159. Bristol Myers PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. Bristol Myers PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Bristol Myers Recent Developments
Table 162. GSK Company Information
Table 163. GSK Description and Major Businesses
Table 164. GSK PDE 4 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. GSK PDE 4 Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. GSK Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. PDE 4 Inhibitors Distributors List
Table 170. PDE 4 Inhibitors Customers List
Table 171. PDE 4 Inhibitors Market Trends
Table 172. PDE 4 Inhibitors Market Drivers
Table 173. PDE 4 Inhibitors Market Challenges
Table 174. PDE 4 Inhibitors Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. PDE 4 Inhibitors Product Picture
Figure 2. Global PDE 4 Inhibitors Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global PDE 4 Inhibitors Market Share by Type in 2022 & 2034
Figure 4. Rolipram Product Picture
Figure 5. Tetomilast Product Picture
Figure 6. Cilomilast Product Picture
Figure 7. Criborole Product Picture
Figure 8. Apremilast Product Picture
Figure 9. Roflumilast Product Picture
Figure 10. Others Product Picture
Figure 11. Global PDE 4 Inhibitors Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 12. Global PDE 4 Inhibitors Market Share by Application in 2022 & 2034
Figure 13. Psoriasis
Figure 14. Chronic Obstructive Pulmonary Disease (COPD)
Figure 15. Asthma
Figure 16. Ankylosing Spondylitis (AS)
Figure 17. Inflammatory Bowel Disease (IBD)
Figure 18. Atopic Dermatitis
Figure 19. Rheumatoid Arthritis (RA)
Figure 20. Systemic Lupus Erythematosus (SLE)
Figure 21. Others
Figure 22. PDE 4 Inhibitors Report Years Considered
Figure 23. Global PDE 4 Inhibitors Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 24. Global PDE 4 Inhibitors Revenue 2024-2034 (US$ Million)
Figure 25. Global PDE 4 Inhibitors Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 26. Global PDE 4 Inhibitors Revenue Market Share by Region (2024-2034)
Figure 27. Global PDE 4 Inhibitors Sales 2024-2034 ((K Units)
Figure 28. Global PDE 4 Inhibitors Sales Market Share by Region (2024-2034)
Figure 29. US & Canada PDE 4 Inhibitors Sales YoY (2024-2034) & (K Units)
Figure 30. US & Canada PDE 4 Inhibitors Revenue YoY (2024-2034) & (US$ Million)
Figure 31. Europe PDE 4 Inhibitors Sales YoY (2024-2034) & (K Units)
Figure 32. Europe PDE 4 Inhibitors Revenue YoY (2024-2034) & (US$ Million)
Figure 33. China PDE 4 Inhibitors Sales YoY (2024-2034) & (K Units)
Figure 34. China PDE 4 Inhibitors Revenue YoY (2024-2034) & (US$ Million)
Figure 35. Asia (excluding China) PDE 4 Inhibitors Sales YoY (2024-2034) & (K Units)
Figure 36. Asia (excluding China) PDE 4 Inhibitors Revenue YoY (2024-2034) & (US$ Million)
Figure 37. Middle East, Africa and Latin America PDE 4 Inhibitors Sales YoY (2024-2034) & (K Units)
Figure 38. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue YoY (2024-2034) & (US$ Million)
Figure 39. The PDE 4 Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 40. The Top 5 and 10 Largest Manufacturers of PDE 4 Inhibitors in the World: Market Share by PDE 4 Inhibitors Revenue in 2022
Figure 41. Global PDE 4 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 42. Global PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
Figure 43. Global PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
Figure 44. Global PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
Figure 45. Global PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
Figure 46. US & Canada PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
Figure 47. US & Canada PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
Figure 48. US & Canada PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
Figure 49. US & Canada PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
Figure 50. US & Canada PDE 4 Inhibitors Revenue Share by Country (2024-2034)
Figure 51. US & Canada PDE 4 Inhibitors Sales Share by Country (2024-2034)
Figure 52. U.S. PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 53. Canada PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 54. Europe PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
Figure 55. Europe PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
Figure 56. Europe PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
Figure 57. Europe PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
Figure 58. Europe PDE 4 Inhibitors Revenue Share by Country (2024-2034)
Figure 59. Europe PDE 4 Inhibitors Sales Share by Country (2024-2034)
Figure 60. Germany PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 61. France PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 62. U.K. PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 63. Italy PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 64. Russia PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 65. China PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
Figure 66. China PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
Figure 67. China PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
Figure 68. China PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
Figure 69. Asia PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
Figure 70. Asia PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
Figure 71. Asia PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
Figure 72. Asia PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
Figure 73. Asia PDE 4 Inhibitors Revenue Share by Region (2024-2034)
Figure 74. Asia PDE 4 Inhibitors Sales Share by Region (2024-2034)
Figure 75. Japan PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 76. South Korea PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 77. China Taiwan PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 78. Southeast Asia PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 79. India PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 80. Middle East, Africa and Latin America PDE 4 Inhibitors Sales Market Share by Type (2024-2034)
Figure 81. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue Market Share by Type (2024-2034)
Figure 82. Middle East, Africa and Latin America PDE 4 Inhibitors Sales Market Share by Application (2024-2034)
Figure 83. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue Market Share by Application (2024-2034)
Figure 84. Middle East, Africa and Latin America PDE 4 Inhibitors Revenue Share by Country (2024-2034)
Figure 85. Middle East, Africa and Latin America PDE 4 Inhibitors Sales Share by Country (2024-2034)
Figure 86. Brazil PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 87. Mexico PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 88. Turkey PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 89. Israel PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 90. GCC Countries PDE 4 Inhibitors Revenue (2024-2034) & (US$ Million)
Figure 91. PDE 4 Inhibitors Value Chain
Figure 92. PDE 4 Inhibitors Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed